Search PubMed⌕ Search

Biomedical subjects

G Evans

Publications and source records attributed to G Evans.

At least 217 records · Page 12Linked to original sources
PubMed1992

Isolation of a zinc finger motif (ZNF75) mapping on chromosome Xq26.

We report here the partial characterization of a new human zinc finger (ZNF75) gene of the Kruppel type mapping to the long arm of the X chromosome. A cosmid clone was isolated from a library specific to the Xq24-qter region by hybridization to a degenerate oligonucleotide representing the link between two contigous fingers of the C2H2 type. The sequence of the pertinent cosmid fragments demonstrated five consecutive zinc finger motifs, all pertaining to the Kruppel family. A reading frame starting at least 75 amino acids before the first zinc finger and ending 11 amino acids after the last one was identified; comparison with other ZF genes suggests that this genomic fragment represents the carboxy-terminal exon of the gene. Homology of approximately 55% in the zinc finger region was detected with many zinc finger genes including mouse Zfp-35 and human ZFN7 cDNA clones. Mapping using a panel of sematic cell hybrids and chromosomal in situ hybridization localized the gene to Xq26, in a region not previously known to contain zinc finger genes.

Amino Acid Sequence↗
PubMed1992

Should prospective NHS employees have routine blood counts?

The results of pre-employment haematological screening from 958 prospective National Health Service (NHS) workers were reviewed. Although many abnormalities were found, few were judged to be clinically significant. In only one case did the examination affect employment. Haematological screening is an unnecessary part of the pre-employment medical assessment of prospective NHS employees.

Adult↗
PubMed1992

Evidence that platelet-activating factor suppresses uterine oxytocin-induced 13,14-dihydro-15-keto-prostaglandin F2 alpha release and phosphatidylinositol hydrolysis in the ewe.

This study was conducted to determine whether platelet-activating factor (PAF) (1) attenuated oxytocin-induced secretion of the prostaglandin (PG) F2 alpha metabolite, PGFM, by the ovine uterus in situ and (2) inhibited the generation of the inositol phosphate secondary messengers by endometrial tissue in response to oxytocin challenge in vitro. Ovariectomized ewes received steroid replacement to mimic the luteal phase. Six ewes received intrauterine injections of 200 micrograms PAF/uterine horn/day on Days 11-15, and 6 ewes were treated with vehicle. All ewes received 1 microgram oxytocin i.v. on Days 13-16. Pretreatment of ewes with PAF significantly suppressed PGFM release in response to oxytocin on Days 14 and 15 (p less than 0.005) compared to vehicle-treated ewes. PAF was not administered on Day 16, and the PGFM response to oxytocin was not different between groups. In a second experiment, ewes were given intrauterine injections of 200 micrograms PAF/uterine horn/day (n = 8) or vehicle (n = 7) on Days 11-15, and all ewes received 1 microgram oxytocin i.v. on Days 13 and 14. On Day 15 the uterus was removed, and the incorporation of 3H-inositol into inositol phosphates was determined in caruncular endometrium. Treatment of ewes with PAF in vivo reduced inositol monophosphate (IP1) generated by oxytocin (10(-6) M) by 56.4%, compared to that in endometrium from vehicle-treated controls, and also inhibited the incorporation of 3H-inositol into glycerophosphoinositol (GPI). If PAF was added to the endometrium during the incubation in vitro, the attenuation of inositol phosphate generation did not occur.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1992

Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia.

Positron-emission tomography was coupled with neurological and neuropsychological evaluation to study regional cerebral activity and neurologic status in two groups. Seventeen patients with full-blown AIDS and 14 seronegative control subjects were studied using [18F]2-fluoro-2-deoxy-D-glucose in a resting state. The AIDS group had relative regional hypermetabolism in the basal ganglia and thalamus; stepwise multiple-regression analyses revealed a significant relationship for the AIDS group between temporal lobe metabolism and severity of dementia on the AIDS Dementia Complex Rating Scale. These results suggest that the basal ganglia, thalamus, and temporal lobes are differentially affected in AIDS.

AIDS Dementia Complex↗
PubMed1992

Luteinizing hormone pulses, follicle-stimulating hormone and control of follicle selection in sheep.

The growth of large oestrogenic follicles that have the potential to ovulate if given an appropriate luteinizing hormone (LH) signal is dictated by the plasma concentration of follicle-stimulating hormone (FSH). Basal amounts of LH are essential for this FSH-induced follicle growth, but pulses of LH do not appear to be essential. The fall in FSH concentration during the follicular phase of the oestrous cycle in sheep, and the subsequent withdrawal of FSH from other developing follicles may not be sufficient to explain follicle selection. There is little evidence to support an active suppression of the growth of other follicles by a factor(s) produced by the dominant, or selected follicle. It is possible that LH pulses cause active atresia of non-selected follicles. The selected follicle is the one that can survive the fall in plasma FSH and the large increase in LH pulses during the follicular phase and selection may simply be a case of being the follicle(s) that is present at the correct time to receive adequate FSH and develop sufficiently to survive the inhibitory effects of LH pulses. Several mechanisms whereby LH pulses may inhibit follicle growth are suggested, and avenues for future research, particularly related to the expression of the LH receptor on granulosa cells of the developing follicle, are outlined.

Animals↗
PubMed1991

Fertility of superovulated ewes following intrauterine or oviducal insemination with fresh or frozen-thawed semen.

Two experiments were conducted with mature Merino ewes to investigate the effects of time and site of insemination of fresh and frozen-thawed semen on the fertility of superovulated ewes. In Experiment 1, each ewe was treated with an intravaginal progestagen sponge and PMSG and/or FSH. They were inseminated in the uterus with fresh or frozen-thawed semen (approximately 100 x 10(6) motile sperm) at 24, 44 or 64 h after sponge withdrawal. Ova were recovered at 88 h after sponge withdrawal and classified as fertilized if they had pronuclei or had cleaved. Mean fertilization rates of recovered ova were 60.0, 93.7 and 87.8% for fresh semen and 46.1, 98.2 and 26.1% for frozen-thawed semen at each of the insemination times (24, 44 and 64 h) respectively. Overall, fertilization rates were higher for fresh semen than for frozen-thawed semen (P less than 0.01), but there was an interaction with time of insemination (P less than 0.01). Following insemination with frozen-thawed semen at 64 h, only 61% of the fertilized ova developed to the 2- to 4-cell stage by the time of embryo recovery; this was less than in any of the other groups (P less than 0.05). In Experiment 2, ewes were inseminated with 100 x 10(6) motile fresh or frozen-thawed semen in the uterus or in the oviducts at 64 h after sponge withdrawal.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1991

Superovulation of Merino ewes with an ovine pituitary follicle stimulating hormone extract.

In order to investigate the effectiveness of ovine FSH as a superovulatory gonadotrophin in sheep, three batches (oFSH-1, oFSH-2 and oFSH-3) of crude follicle stimulating hormone (FSH) extracts were prepared from ovine pituitaries by protein fractionation. The extracts were characterized in radioimmunoassays (RIA), radioreceptor assays (RRA) and bioassays. A FSH:LH (luteinizing hormone) ratio of 1:0.71 and 1:0.18 was calculated from oFSH-1 in RIA and RRA respectively. oFSH-1 was more potent than NIH-oFSH-S12 in RRA, with a potency ratio of 1:0.65 calculated at 50% binding. In mouse bioassay, oFSH-2 was effective in inducing folliculogenesis. The potency of oFSH-3 as an ovarian stimulatory hormone was tested in a field trial on sheep. Thirty-one mature Merino ewes were treated in the breeding season with intravaginal progestagen pessaries and 6, 12 or 24 mg doses of oFSH-3 were injected twice daily for 3 days (n = 10 or 11). Each ewe was inseminated in the uterus with fresh semen 24 h after pessary withdrawal. Ova or embryos were recovered by mid-ventral laparotomy 6 or 7 days after pessary withdrawal. The dose of oFSH-3 had a significant effect on the ovulatory response (P less than 0.01); the mean ovulation rates were 1.5 +/- 0.2, 12.6 +/- 2.8 and 13.1 +/- 2.9 following injection with 6, 12 or 24 mg of the gonadotrophin respectively. The dose of the gonadotrophin injected had no effect on the mean percentages of ova recovered or fertilized. The overall ova recovery and fertilization rates (%) were 67.8 +/- 6.4 and 92.2 +/- 5.1 respectively. (ABSTRACT TRUNCATED AT 250 WORDS)

Analysis of Variance↗
PubMed1991

Application of reproductive technology to the Australian livestock industries.

Current use of reproductive technology in the Australian livestock industries is limited, though it increased in line with higher prices for beef and wool through the 1980s. The required techniques, many of which were developed in Australia, are available and the level of expertise is comparable to the best in the world. However, the extensive pastoral industries do not readily lend themselves to these procedures. Only in the dairy industry is artificial insemination used to a significant degree. On the other hand, application of the technology in the pastoral industries is confined largely to studs and breeding cooperatives which provide breeding animals for producer flocks and herds. Hence the impact of applied technology may be more widespread than first appears. Until recently, little regard was paid to application of the technology along sound breeding principles. Artificial insemination and multiple ovulation and embryo transfer (MOET) have not been used so much in planned breeding programmes aimed at local improvement of stock, but more to proliferate genes of reputedly superior stock, imported either from overseas or elsewhere in Australia. This is particularly true of MOET, where the incentive to use it is commonly a short term cash gain made from proliferating breeding stock of a particularly valuable and usually novel strain or breed. Recent technological improvements which render the use of reproductive technology cheaper and more effective will lead to its more widespread use in commercial practice. Techniques for embryo freezing and splitting have been greatly simplified and quickly put into practice. The novel livestock technologies of in vitro oocyte maturation and fertilization have already found commercial application overseas. Fecundity-enhancing products have also been adopted by the livestock industries. There is potential value for greater use of reproductive technology in the livestock industries provided it is implemented according to sound breeding principles and provided associated management practices are applied simultaneously.

Animals↗
PubMed1991

Effects of season, GnRH administration and lupin supplementation on the ovarian and endocrine responses of merino ewes treated with PMSG and FSH-P to induce superovulation.

Administration of gonadotrophin releasing hormone (GnRH) 24 h after sponge withdrawal did not affect the numbers of corpora lutea (CL) or persistent large follicles (LF) in ewes superovulated with 400 I.U. pregnant mare serum gonadotrophin and 12 mg follicle stimulating hormone in spring (11.6 +/- 0.9 v. 13.0 +/- 0.9 CL and 0.8 +/- 0.9 v. 0.9 +/- 0.3 LF, for +GnRH and -GnRH ewes, respectively). However, it did increase the ovulatory response of ewes superovulated in autumn (15.8 +/- 1.2 v. 11.8 +/- 1.1 CL). The incidence of ewes with prematurely regressed CL was also greater in autumn than in spring (21/89 v. 5/88). Supplementary feeding with lupin grain in autumn had no effect on numbers of CL but did increase the incidence of ewes with LF (18/48 v. 7/46) and caused a marked reduction in the incidence of ewes with regressed CL (1/44 v. 20/45). For ewes treated in autumn, there were no effects of lupin supplementation or GnRH administration on peak oestradiol-17 beta (E2) or peak luteinizing hormone (LH) levels. However, when peak E2 concentrations in the plasma were adjusted for numbers of preovulatory follicles, higher concentrations were observed for ewes in the +lupin/-GnRH group (12.4 +/- 2.9 pg mL-1) than in other treatment groups (range 4.3 +/- 0.4 to 5.7 +/- 0.3 pg mL-1). Moreover, the time of the LH peak was advanced by both lupin supplementation and GnRH treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Animal Feed↗
PubMed1991

Drug contamination from opening glass ampules.

Recently there have been several reports of postoperative sepsis due to the intravenous injection of contaminated solutions of propofol (Diprivan). The mechanism by which this contamination occurred has not been identified. This study sought to determine whether bacterial contamination of the contents of glass ampules can be decreased by swabbing the neck of the vial with alcohol prior to opening. Glass ampules of 1% propofol and 1% lidocaine were swabbed with a solution of Staphylococcus epidermidis. Half of these ampules were subsequently wiped with alcohol pads prior to being opened. An aliquot from each ampule was pipetted into a nutrient broth and allowed to incubate overnight at 37 degrees C. These solutions were plated on agar, incubated for 24 h, and then examined for bacterial growth. Three of the eight lidocaine ampules and six of the eight propofol ampules not cleaned with alcohol demonstrated evidence of bacterial contamination. The contents of all ampules that had been wiped with alcohol prior to being opened remained sterile (P less than 0.001 vs. non-alcohol-treated group for propofol ampules and P = 0.20 vs. non-alcohol-treated group for lidocaine ampules). These data suggest that bacterial contamination of propofol and lidocaine may occur as a result of opening glass ampules. Wiping the outside of the ampule with alcohol immediately prior to opening may decrease this risk.

Alcohols↗
PubMed1991

Conception rates in European fallow does (Dama dama dama) following intrauterine insemination with frozen-thawed semen from Mesopotamian fallow (Dama dama mesopotamica) and crossbred (Dama dama dama x Dama dama mesopotamica) bucks.

Ninety eight parous fallow does received laparoscopic intrauterine insemination of frozen-thawed semen at one of 2 fixed intervals following oestrus synchronisation treatment. Semen was collected from a Mesopotamian (Dama dama mesopotamica) and a crossbred (F1) (Dama dama dama x Dama dama mesopotamica) fallow buck. Does were inseminated at either 56 or 66 hours after the removal of an intravaginal controlled internal drug releasing device. Eighty eight does received a single straw of frozen-thawed semen containing a total of 50 x 10(6) spermatozoa, while the remaining 10 received split straws containing 25 x 10(6) spermatozoa. Overall, the use of F1 semen containing 50 x 10(6) spermatozoa resulted in a 68% (17/25) conception rate compared with the Mesopotamian semen, which resulted in a 41% (26/63) conception rate. Conceptions were also achieved using 25 x 10(6) spermatozoa of either Mesopotamian or F1 semen (3/8 versus 2/2, respectively). Overall, the conception rate was higher for F1 than Mesopotamian semen (P less than 0.025) and there was a significant interaction with time of insemination (P less than 0.05); for F1 semen there was no difference in conception rate at the 2 insemination times, but for Mesopotamian semen conception was significantly higher (P less than 0.005) following insemination at 66 hours than at 56 hours.

Animals↗
PubMed1991

Increased ovulation rate in androstenedione-immune ewes is not due to elevated plasma concentrations of FSH.

Two experiments were undertaken to determine the hormonal response of Merino ewes to immunization against androstenedione (Fecundin). In Exp. 1 peripheral concentrations of LH, FSH and progesterone were monitored in spontaneously cycling ewes (20 immunized and 21 controls). In Exp. 2 (10 immunized and 10 controls) the same hormones were measured in ewes before and after prostaglandin (PG)-induced luteolysis and, in addition, the pattern of pulsatile LH secretion was determined during the luteal (PG + 12 days), early follicular (PG + 24 h) and late follicular (PG + 40 h) phase of the oestrous cycle. Ovulation rates were measured in both experiments. The results of these experiments indicate that androstenedione-immune animals have elevated ovulation rates (0.6-0.7 greater than control animals; P less than 0.05) associated with elevated plasma concentrations of LH and progesterone. The magnitude of the increase in plasma progesterone was correlated with androstenedione antibody titre (r = 0.6, P less than 0.001). LH pulse frequency of androstenedione-immune ewes tended to be higher at all stages of the oestrous cycle, but this difference was only significant (P less than 0.05) during the luteal phase. Mean plasma concentrations of FSH did not differ significantly between immunized and control ewes at any stage of the cycle. Analysis of periodic fluctuations in FSH during the luteal phase revealed that androstenedione-immune animals had a similar number of fluctuations of a similar amplitude to those of control animals, but the nadir of these fluctuations was lower (P less than 0.05) in immunized animals. A significant (P less than 0.05) negative correlation existed between androstenedione antibody titre and the interval between FSH peaks (r = -0.49) and androstenedione antibody titre and FSH nadir concentrations (r = -0.46). It is concluded that plasma FSH concentrations are not a determinant of ovulation rate in androstenedione-immune ewes and that increased LH concentrations, or perturbation of normal intraovarian mechanisms, may be responsible for the increase in ovulation rate observed in ewes immunized against androstenedione.

Androstenedione↗
PubMed1991

Production of platelet-activating factor by the pre-implantation sheep embryo.

Embryos were collected from superovulated ewes on Day 2 (2-8 cell), Day 4 (8-16 cell) and Day 6 (morula/early blastocyst). Two embryos were cultured in 1 ml of one of four media: (i) Ham's F10 + 4 mg bovine serum albumin (BSA)/ml, (ii) synthetic oviduct fluid medium + 20% human serum, (iii) Quinn's human tubal fluid medium (HTF) + 3 mg BSA/ml or (iv) HTF + 10% acid-treated fetal calf serum for 24 h. They were transferred to fresh media of the same type and their further development was monitored. A quantitative bioassay and radioimmunoassay was used to measure the concentration of platelet-activating factor (PAF, 1-o-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine) produced. Following extraction and partial purification, 21/95 (22.1%) of the embryo-conditioned media samples had PAF concentrations greater than that measured in corresponding control media. This was designated as embryo-derived PAF and the corresponding cultures were termed 'PAF-positive'. PAF was produced by embryos at all three developmental stages examined and in each of the four media used, and the average amount of PAF produced was 60.9 +/- 9.8 pmol/embryo/24 h. However, neither the developmental stage of the embryo, nor the type of media affected the proportion of PAF-positive cultures nor the amount of PAF produced during culture. Thus, it is demonstrated for the first time that early ovine embryos can secrete PAF in vitro, and that there is considerable variability in their capacity for PAF secretion.

Animals↗
PubMed1991

Histological and clinical comparisons of guided tissue regeneration on dehisced hydroxylapatite-coated and titanium endosseous implant surfaces: a pilot study.

Fifty-six endosseous cylindrical implants were placed in dog mandibles 12 weeks after the extraction of all mandibular premolars and first molars. Eight implants, four coated with 50 microns of hydroxylapatite (HA) and four grit-blasted and titanium-surfaced, were placed in each dog. Ideal implant placement sites were modified by creating standardized 3 x 5-mm facial dehiscence defects. Half the dehiscences were treated with a modified expanded polytetrafluoroethylene (PTFE) membrane; the remainder served as controls. After 8 weeks of healing, the animals were sacrificed and measurements made to determine the percentage of dehiscence repair. The HA-coated implants had a mean defect fill of 95.17% and the grit-blasted implants had a percent fill of 82.8% in the guided tissue regeneration (GTR) test group; the control implants demonstrated a mean fill of 55% and 39% in the HA-coated and grit-blasted implants, respectively. Significant differences (P less than .05) were noted between both test groups and the titanium control group, and between the HA test and HA control groups. Histologic evaluation showed significantly greater repair associated with HA-coated implants, as well as significant bone loss associated with clinically exposed membranes. It was concluded that within the limitations of this study, guided tissue regeneration is a viable option in treating defects associated with dental implants.

Alveolar Bone Loss↗
PubMed1990

Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain.

Previous results suggested that, after intranasal inoculation, mouse hepatitis virus (MHV), a neurotropic coronavirus, entered the central nervous system (CNS) via the olfactory and trigeminal nerves. To prove this hypothesis, the effect of interruption of the olfactory pathway on spread of the virus was studied using in situ hybridization. Unilateral surgical ablation of this pathway prevented spread of the virus via the olfactory tract on the side of the lesion. MHV RNA could be detected, however, at distal sites on the operated side, indicating that the virus spread via well-described circuits involving the anterior commissure from the control (intact) side of the brain. Viral transport via the trigeminal nerve was not affected by removal of the olfactory bulb, showing that the surgical procedure was specific for the olfactory pathway. These results prove conclusively that MHV gains entry to the CNS via a transneuronal route, and spreads to additional sites in the brain via known neuroanatomic pathways.

Animals↗